Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

Core Insights - Oragenics, Inc. has announced the appointment of Dr. James Kelly as a member of the Medical Board of The Leigh Steinberg Foundation, which focuses on concussion and brain health [1][2][4] - Dr. Kelly's leadership in brain injury research and treatment is recognized, enhancing his influence in the field of concussion care [2][3] - The foundation aims to advance brain health through research, awareness, and actionable solutions for those affected by concussions and traumatic brain injuries [2][6] Company Overview - Oragenics, Inc. is a clinical-stage biotechnology company dedicated to developing innovative treatments for neurological disorders, with its lead asset being ONP-002, an intranasal therapy for concussion [5] - The company emphasizes its commitment to pioneering new approaches in neuroscience to improve patient outcomes [5] Leadership and Contributions - Dr. Kelly has a distinguished background, having previously served as the founding director of the National Intrepid Center of Excellence, where he advanced the diagnosis and treatment of brain injuries, particularly for military personnel [3] - His experience includes working with athletes and individuals affected by concussions, positioning him as a key advocate for improved care and research [3] Foundation's Mission - The Leigh Steinberg Foundation is dedicated to raising awareness and supporting research for better care strategies for individuals suffering from brain injuries, especially in sports and military communities [6] - Dr. Kelly's involvement with the foundation aligns with Oragenics' mission to advance brain injury treatment and improve patient outcomes [4]